As of 2026-03-06, the Relative Valuation of Viracta Therapeutics Inc (VIRX) is (188.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Viracta Therapeutics Inc based on Relative Valuation is -242629.6%.
The range of the Relative Valuation is (186.53) - (199.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 24.5x | 21.6x |
| Forward P/E multiples | 20.5x - 23.1x | 22.1x |
| Fair Price | (186.53) - (199.66) | (188.69) |
| Upside | -239854.6% - -256726.2% | -242629.6% |
| Date | P/E |